Farzana Nazimuddin

4.8k citations
11 papers · 958 indexed · 1 hit paper · h-index 9
Topics
CAR-T cell therapy research (11 papers)Acute Lymphoblastic Leukemia research (6 papers)Neuroblastoma Research and Treatments (1 paper)
Partner nations
United StatesCanada

In The Last Decade

Farzana Nazimuddin

11 papers receiving 950 citations

Hit Papers

Activity of Mesothelin-Specific Chimeric Antigen Receptor...20182026202020232018100200300

Peers

Farzana Nazimuddin
Comparison fields: 5 of 44
  • Oncology 865
  • Immunology 276
  • Genetics 262
  • Biomedical Engineering 234
  • Molecular Biology 213
Replace Brock Lanier with:
Brock Lanier United States
Reona Sakemura United States
Hejin Jia China
Anthony F. Daniyan United States
Liqing Kang China
Brandon Ballard United States
Stefanie Lesch Germany
Diogo Gomes‐Silva United States
Christopher Hunt Keir United States
Oumar Diouf United States
Farzana Nazimuddin relative to Brock Lanier United States Brock Lanier's profile →
Citations per field
00.5×1.5×1.9×
Brock Lanier · 1×
Citations per year

Countries citing papers authored by Farzana Nazimuddin

Since Specialization
Citations

This map shows the geographic impact of Farzana Nazimuddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzana Nazimuddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzana Nazimuddin more than expected).

Fields of papers citing papers by Farzana Nazimuddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzana Nazimuddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzana Nazimuddin. The network helps show where Farzana Nazimuddin may publish in the future.

Co-authorship network of co-authors of Farzana Nazimuddin

This figure shows the co-authorship network connecting the top 25 collaborators of Farzana Nazimuddin. A scholar is included among the top collaborators of Farzana Nazimuddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzana Nazimuddin. Farzana Nazimuddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trialbreakdown →
379
2 121
3 79
4 14
5 117
6 20
7 192
8 5
9 9
10 4
11 18

About Farzana Nazimuddin

Farzana Nazimuddin is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 11 papers that have together received 958 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Acute Lymphoblastic Leukemia research (6 papers) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Oncology (865 citations), Immunology (276 citations) and Genetics (262 citations). Farzana Nazimuddin has collaborated with scholars based in United States and Canada. Frequent co-authors include Simon F. Lacey, Carl H. June, J. Joseph Melenhorst, Bruce L. Levine, David L. Porter, Shannon L. Maude, Colleen Callahan, Irina Kulikovskaya, Mark H. O’Hara and Anne Marie Nelson. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026